Last Updated on
The U.S. Food and Drug Administration warned two companies to stop illegally marketing CBD products with claims that it can treat opioid addiction and other medical conditions.
The warning letters were sent Thursday to:
- BIOTA Biosciences, LLC, of Washington state
- Homero Corp., doing business as Nature’s CBD Oil Distribution of New Hampshire
“CBD has not been shown to treat opioid addiction. Opioid addiction is a real problem in our country, and those who are addicted need to seek out proper treatment from a health care provider,” FDA Principal Deputy Commissioner Amy Abernethy said a statement about the warnings.
The FDA accuses both companies of marketing and distributing CBD products for serious diseases and as an alternative to opioids.
The letters give the companies 15 days to demonstrate how they’ll correct the violations.
To read more about marketing CBD without running afoul of the FDA, click here.
We are not the original authors of this article. This content was republished from HempIndustryDaily.com.